This study is testing whether a new weekly injection called nimacimab helps people lose weight. Researchers are comparing it to a placebo (dummy shot) and to nimacimab given alongside the approved weight-loss medication semaglutide (Wegovy). The goal is to see if nimacimab is saf…
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC